| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 196.55M | 111.92M | 66.40M | 44.71M | 22.59M | 1.22M |
| Gross Profit | 172.01M | 100.55M | 59.91M | 38.83M | 8.39M | 710.01K |
| EBITDA | 76.02M | 6.76M | 23.78M | 34.81M | 1.03M | 662.02K |
| Net Income | 11.04M | -23.96M | 9.52M | 31.68M | 997.41K | 662.02K |
Balance Sheet | ||||||
| Total Assets | 918.94M | 874.16M | 331.83M | 59.09M | 1.84M | 1.46M |
| Cash, Cash Equivalents and Short-Term Investments | 86.42M | 131.94M | 27.84M | 30.05M | 102.42K | 135.27K |
| Total Debt | 414.48M | 385.91M | 141.74M | 28.33M | 1.05M | 148.97K |
| Total Liabilities | 479.34M | 450.87M | 167.76M | 30.95M | 1.07M | 160.70K |
| Stockholders Equity | 439.59M | 424.15M | 163.93M | 27.25M | 915.05K | 2.08M |
Cash Flow | ||||||
| Free Cash Flow | -111.14M | -209.62M | -64.71M | 10.61M | 1.12M | 650.13K |
| Operating Cash Flow | -110.22M | -208.81M | -64.52M | 10.69M | 1.34M | 650.13K |
| Investing Cash Flow | -17.77M | -4.96M | 2.24M | -3.70M | -241.53K | -1.25M |
| Financing Cash Flow | 195.00M | 320.12M | 57.82M | 22.96M | -354.58K | 697.81K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | $3.67B | 4.37 | 16.27% | ― | 27.71% | ― | |
71 Outperform | $3.88B | 14.50 | 11.12% | 1.54% | -1.61% | 15.79% | |
68 Neutral | $804.51M | 106.53 | 3.17% | ― | 91.78% | ― | |
68 Neutral | $55.28M | 12.02 | 4.75% | 0.74% | 11.99% | ― | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
63 Neutral | $3.25B | 15.41 | 2.86% | ― | 1.41% | 150.35% | |
59 Neutral | $277.64M | 25.84 | 5.02% | ― | -0.55% | -51.14% |
In a shareholder letter released on January 8, 2026, Abacus Global Management reported that 2025 was a defining year, highlighted by record third-quarter results with year-over-year revenue growth of 124%, adjusted net income growth of 60%, adjusted EBITDA growth of 127% with 60% margins, and 10 consecutive quarters of beating earnings expectations. The company raised its full-year 2025 adjusted net income guidance to $80–$84 million, reflecting 72%–81% growth and a higher earnings and cash-flow baseline, while advancing a strategic shift from largely transactional income toward a recurring revenue model—currently about 15% of revenue, with a long-term target of 70%—supported by assets under management rising to $3.33 billion and strengthened by the acquisition of digital life insurance platform AccuQuote and the introduction of a dividend and share repurchase program. Abacus underscored key milestones including the completion of a $50 million investment-grade securitized note backed by life insurance assets, which broadens institutional distribution and establishes a repeatable, lower-cost funding mechanism while generating ongoing servicing fees, and the planned 2026 launch of an asset-based finance investing strategy aimed at deploying third-party capital into asset-backed lending and structured credit, leveraging the firm’s actuarial expertise and insurance infrastructure in a market it estimates at more than $20 trillion. Management emphasized a robust balance sheet, record cash generation, and confidence that growth can be funded without additional equity issuance—implying no expected shareholder dilution—while also addressing the company’s valuation discount relative to faster-growing alternative asset management peers and outlining intensified investor outreach efforts designed to increase transparency, highlight fee-related earnings, and close the gap in market perception.
The most recent analyst rating on (ABX) stock is a Hold with a $9.00 price target. To see the full list of analyst forecasts on Abacus Global Management stock, see the ABX Stock Forecast page.